{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:55:58Z","timestamp":1787007358177,"version":"build-2736575974"},"reference-count":23,"publisher":"Informa UK Limited","issue":"36","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Genmab A\/S"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2024,11,16]]},"DOI":"10.1080\/14796694.2024.2393566","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T08:02:16Z","timestamp":1726214536000},"page":"2855-2868","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Logistical challenges of CAR T-cell therapy in non-Hodgkin lymphoma: a survey of healthcare professionals"],"prefix":"10.1080","volume":"20","author":[{"given":"Anna","family":"Sureda","sequence":"first","affiliation":[{"name":"Institut Catal\u00e0 d'Oncologia, Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiraz El","family":"Adam","sequence":"additional","affiliation":[{"name":"Broadstreet HEOR, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibing","family":"Yang","sequence":"additional","affiliation":[{"name":"Genmab US, Inc., Plainsboro, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Griffin","sequence":"additional","affiliation":[{"name":"Broadstreet HEOR, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Baker","sequence":"additional","affiliation":[{"name":"Broadstreet HEOR, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karissa","family":"Johnston","sequence":"additional","affiliation":[{"name":"Broadstreet HEOR, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Rivas","family":"Navarro","sequence":"additional","affiliation":[{"name":"Genmab US, Inc., Plainsboro, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Alhasani","sequence":"additional","affiliation":[{"name":"Genmab US, Inc., Plainsboro, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindit","family":"Chhibber","sequence":"additional","affiliation":[{"name":"Genmab US, Inc., Plainsboro, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Wang","sequence":"additional","affiliation":[{"name":"Abbvie Inc., North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Mutebi","sequence":"additional","affiliation":[{"name":"Genmab US, Inc., Plainsboro, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"issue":"5","key":"e_1_3_7_3_1","first-page":"309","article-title":"CAR T-cell therapy for relapsed\/refractory non-Hodgkin's lymphoma: a comprehensive review","volume":"20","author":"St-Pierre F","year":"2022","unstructured":"St-Pierre F, Gordon LI. CAR T-cell therapy for relapsed\/refractory non-Hodgkin's lymphoma: a comprehensive review. Clin Adv Hematol Oncol. 2022;20(5):309\u2013318.","journal-title":"Clin Adv Hematol Oncol."},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01622-0"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00591-X"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31366-0"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914347"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2020.2103"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_397912"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2021.88737"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-5546"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01839-y"},{"key":"e_1_3_7_15_1","unstructured":"Directory of CAR T-cell therapy centers: Blood & Marrow Transplant Information Network. 2023 [6 November 2023]. Available from: https:\/\/www.bmtinfonet.org\/car-t-cell-therapy-center-directory Accessed August 9 2024."},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.12927\/hcpol.2021.26430"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.04.989"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2020-0118"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-0160"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.5674"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2072"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.22.00315"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27155"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009019"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2024.2393566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T08:22:58Z","timestamp":1731658978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2024.2393566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":23,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2024,11,16]]}},"alternative-id":["10.1080\/14796694.2024.2393566"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2024.2393566","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}